Loop Industries, Inc. Executive Salary: Equity Awards and Other Pay Tables
Every other executive pay table in the proxy statement (grants of awards, outstanding awards, options exercised and stock vested, deferred pay, payments on leaving or a change in control), one row per person per table, with each filed column and value.
- 2026: Table Outstanding Equity Awards at Fiscal Year-End; Person Daniel Solomita.
- 2026: Table Outstanding Equity Awards at Fiscal Year-End; Person Adel Essaddam.
- 2026: Table Outstanding Equity Awards at Fiscal Year-End; Person Spencer Hart.
| Fiscal year | Table | Person | As filed |
|---|---|---|---|
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Daniel Solomita | : Daniel Solomita(1) Option Awards | Number of shares or units of stock that have not vested (#): 2,000,000 Stock Awards | Market Value of shares or units of stock that have not vested ($): 2,600,000 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Daniel Solomita | Option Awards | Number of Securities Underlying Unexercised Options Exercisable (#): 181,922 Option Awards | Option Exercise Price ($): 1.16 Option Awards | Option Expiration date: April 4, 2032 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Daniel Solomita | Option Awards | Number of Securities Underlying Unexercised Options Unexercisable (#): 1,500,000 Option Awards | Option Exercise Price ($): 1.16 Option Awards | Option Expiration date: April 4, 2032 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Adel Essaddam | : Adel Essaddam(2) Option Awards | Number of shares or units of stock that have not vested (#): 12,299 Stock Awards | Market Value of shares or units of stock that have not vested ($): 15,979 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Adel Essaddam | Option Awards | Number of Securities Underlying Unexercised Options Exercisable (#): 350,000 Option Awards | Option Exercise Price ($): 12.00 Option Awards | Option Expiration date: September 14, 2027 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Adel Essaddam | Option Awards | Number of Securities Underlying Unexercised Options Exercisable (#): 250,000 Option Awards | Number of Securities Underlying Unexercised Options Unexercisable (#): 74,000 Option Awards | Option Exercise Price ($): 2.68 Option Awards | Option Expiration date: November 28, 2032 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Adel Essaddam | Option Awards | Number of Securities Underlying Unexercised Options Exercisable (#): 18,093 Option Awards | Number of Securities Underlying Unexercised Options Unexercisable (#): 54,278 Option Awards | Option Exercise Price ($): 2.89 Option Awards | Option Expiration date: March 7, 2034 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Adel Essaddam | Option Awards | Number of Securities Underlying Unexercised Options Exercisable (#): 350,000 Option Awards | Option Exercise Price ($): 1.16 Option Awards | Option Expiration date: April 4, 2032 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Adel Essaddam | Option Awards | Number of Securities Underlying Unexercised Options Unexercisable (#): 200,000 Option Awards | Option Exercise Price ($): 1.16 Option Awards | Option Expiration date: April 4, 2032 |
| 2026 | Outstanding Equity Awards at Fiscal Year-End | Spencer Hart | : Spencer Hart(3) Option Awards | Number of Securities Underlying Unexercised Options Exercisable (#): 200,000 Option Awards | Number of Securities Underlying Unexercised Options Unexercisable (#): 800,000 Option Awards | Option Exercise Price ($): 1.02 Option Awards | Option Expiration date: January 4, 2033 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GULF RESOURCES, INC. (GURE) | $0.006B | ||
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |